Cannabix Technologies Inc. (BLOZF)
OTCMKTS · Delayed Price · Currency is USD
0.4264
-0.0051 (-1.19%)
Aug 12, 2025, 3:50 PM EDT
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of $51.93 million as of August 13, 2025. Its market cap has increased by 27.45% in one year.
Market Cap
51.93M
Enterprise Value
49.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.43
Market Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 540.03K to 51.93M, an increase of 9,515.71%. That is a compound annual growth rate of 47.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 51.93M | 102.78% |
| Dec 31, 2024 | 25.61M | 64.60% |
| Dec 29, 2023 | 15.56M | -43.24% |
| Dec 30, 2022 | 27.41M | -43.72% |
| Dec 31, 2021 | 48.71M | -34.40% |
| Dec 31, 2020 | 74.25M | 147.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |